Short axis < 15 mm or benign texture (fatty hilum, calcification, smooth margins) → no further work-up. ≥ 15 mm: explainable disease → management per that disease; no explainable disease → clinical consultation and/or FDG PET/CT and/or 3–6 month follow-up CT (increased → PET/CT or biopsy; stable/decreased → no further work-up).
Anterior/middle compartment: cystic → no further work-up; not cystic → MRI or PET/CT. Posterior compartment → MRI (high likelihood of neurogenic origin).
Cyst HU ≤ 10 → no further work-up. Cyst HU > 10, thickened pericardium (> 3–4 mm), effusion > 50 mL, or calcification: explainable disease → management per disease; no explainable disease → consider MRI or short-term CT follow-up.
Ascending aorta and root: dilated 4.0–4.4 cm, aneurysm ≥ 4.5 cm, on absolute size. The 2022 ACC/AHA aortic disease guideline replaces the 1.5×-expected-normal rule here, because it fails in these two segments, and prefers “dilated” to “ectatic”. Descending: the 1.5× rule still holds — upper-normal ≈ 3.0 cm, aneurysm ≥ 4.0 cm; gender-dependent. Diameter ≥ 5.5 cm → high rupture risk, consider intervention. Connective-tissue disease (Marfan/Ehlers-Danlos) with ascending ≥ 5.0 cm → consider prophylactic aortic root replacement.
Report presence/absence in all patients (Agatston or visual none/mild/moderate/heavy-severe). Heavy or severe CAC should be further evaluated.
Main pulmonary artery ≥ 3.0 cm, or equal to/greater than the ascending aorta diameter, should be reported as dilated. May reflect pulmonary arterial hypertension or be secondary to chronic PE / lung disease.
Munden RF, et al. Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2018;15:1087–1096.